Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The test substance was tested for acute oral toxicity to rats according to OECD guideline No. 423: "Acute Oral Toxicity, Acute Toxic Class Method", adopted 2001 and Commission regulation (EC) No. 440/2008 of 30 May 2008, Part B.1 tris: “Acute Oral Toxicity, Acute Toxic Class Method”, Publication No. L142.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2014-07-08 to 2014-08-19
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted under GLP conditions in accordance with the OECD guideline No 423 (2001).
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
(2001)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Version / remarks:
(May, 2008)
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Version / remarks:
(2002)
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
no
Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Strain: Wistar Crl: WI (Han)
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: young adult animals (8-9 weeks)
- Weight at study initiation: 143 - 185 g
- Fasting period before study: overnight prior to dosing and until 3-4 hours after administration of the test substance
- Housing: group housing of 3 animals per cage
- Diet (e.g. ad libitum): pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany) ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark
Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Justification for choice of vehicle: The vehicle was selected based on trial formulations performed at WIL Research Europe and on test substance data supplied by the sponsor.

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: assumed low toxic effects
Doses:
2000 mg/kg (10 mL/kg) body weight.
300 mg/kg (10 mL/kg) body weight.
No. of animals per sex per dose:
3 animals per dose (total of 12 animals)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Days 1 (pre-administration), 8 and 15 and at death (if found dead or sacrificed after Day 1).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
No statistical analysis was performed.
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 2 000 mg/kg bw
Based on:
test mat.
Mortality:
At 2000 mg/kg, three out of six animals were found dead on Day 2 or 3.
At 300 mg/kg, no mortality occurred.
Clinical signs:
At 2000 mg/kg, lethargy, hunched posture, piloerection, ptosis and/or diarrhea were noted for the animals between Days 1 and 9.
At 300 mg/kg, hunched posture and/or piloerection, were noted for the animals on Day 1.
Body weight:
At 2000 mg/kg, one of the surviving animals showed slight body weight loss between Days 1 and 8. Other animals showed expected body weight gain.
Gross pathology:
At 2000 mg/kg, abnormalities of the stomach and small intestines (contents: gelatinous) were found in one of the animals found dead.

Table 1. Mean body weights

Sex / dose level

Mean weight +/- St.Deviation (g)

Day 1

Day 8

Day 15

Females 2000 mg/kg

153 +/- 9

166 +/- 8

196 +/- 1

Females 2000 mg/kg

176 +/- 11

174

198

Females 300 mg/kg

177 +/- 8

198 +/- 9

209 +/- 7

Females 300 mg/kg

157 +/- 7

187 +/- 6

202 +/- 11

Interpretation of results:
Toxicity Category IV
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.
Executive summary:

The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.

According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.

Based on these results:

- according to the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments),

Lithium salt of branched-aliphatic dicarboxylic acid should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route.

- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments),

Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Category 4 and should be labelled as H302: Harmful if swallowed.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Additional information

The acute oral toxicity of Lithium salt of branched-aliphatic dicarboxylic acid to rats was evaluated in a reliable study according to the appropriate standard test methods EU Method B.1 tris (Acute Oral Toxicity, Acute Toxic Class Method), OECD Guideline 423 (Acute Oral Toxicity - Acute Toxic Class Method) and EPA, OPPTS870.1100 (2002) “Acute Oral Toxicity”.

The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.

According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.

Based on these results:

- according to the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route.

- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Category 4 and should be labelled as H302: Harmful if swallowed.


Justification for selection of acute toxicity – oral endpoint
The study was conducted under GLP conditions according to OECD guideline 429 and matched the requirements of Annex 7 of the REACH legislation.

Justification for classification or non-classification

The LD50 cut-off value was considered to be 2000 mg/kg body weight.

According to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Harmful if swallowed (Category 4) for acute toxicity by the oral route.